Associate Professor, Internal Medicine, St Louis University School of Medicine
Nephrology
Dr. Krista L. Lentine, MD
|
|
Give Review
Dr. Krista L. Lentine is an expert in the field of Nephrology. He researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care He received 1 awards: "Fellow (ASNF)". Dr. Krista L. Lentine is a published doctor. He published 99 publications, including: 'A developmentally regulated chromosomal origin of replication uses essential transcription elements.' Dr. Krista L. Lentine accepts Medicare payments and is listed with Medicare.gov.
Publications
- Pro: Pretransplant weight loss: yes.
- Opponent's comments.
- Clinical and Economic Consequences of First-Year Urinary Tract Infections, Sepsis and Pneumonia in Contemporary Kidney Transplantation Practice.
- Functional Status Metrics in Kidney Transplantation: Implications for Patients, Programs, and Policy Makers.
- Gestational Hypertension and Preeclampsia in Living Kidney Donors.
- Clopidogrel use as a risk factor for poor outcomes after Kidney transplantation.
- Prognostic impact of mechanical ventilation after liver transplantation: a national database study.
- End-stage renal disease risk in live Kidney donors: what have we learned from two recent studies?
- Transplantation: The relevance of the FAVORIT blood pressure associations.
- Clinical correlates, outcomes and healthcare costs associated with early mechanical ventilation after Kidney transplantation.
- Better Understanding Live Donor Risk through Big Data.
- Transplant certification and quality assessment: time to take the front line?
- Health outcomes among non-Caucasian living Kidney donors: knowns and unknowns.
- Health-related quality of life in Kidney transplant patients with diabetes.
- Following the organ supply: assessing the benefit of inter-DSA travel in liver transplantation.
- The cost implications of first anniversary renal function after living, standard criteria deceased and expanded criteria deceased donor Kidney transplantation.
- The implications of Acute rejection for allograft survival in contemporary U.S. kidney transplantation.
- The implications of Acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation.
- Cancer diagnoses after living Kidney donation: linking U.S. Registry data and administrative claims.
- Cardiac Catheterization in the Dialysis Population in 2012: We Know More, but Much Remains Unknown.
- Use of 12-Month Renal Function and Baseline Clinical Factors to Predict Long-Term Graft Survival: Application to BENEFIT and BENEFIT-EXT Trials.
- Joint Association of Hyperuricemia and Reduced GFR on Cardiovascular Morbidity: A Historical Cohort Study Based on Laboratory and Claims Data From a National Insurance...
- The economic impact of addressing the organ shortage With clinically high-risk allografts.
- Associations of renal function at 1-year after Kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs.
- Interpreting body composition in Kidney transplantation: weighing candidate selection, prognostication, and interventional strategies to optimize health.
- Cardioprotective Medication Use After Acute Myocardial Infarction in Kidney Transplant Recipients.
- Associations of Recipient Illness History With Hypertension and Diabetes After Living Kidney Donation.
- The interaction among donor characteristics, severity of liver Disease, and the cost of liver transplantation.
- The interplay of socioeconomic status, distance to center, and interdonor service area travel on Kidney transplant access and outcomes.
- Incidence, predictors, costs, and outcome of renal cell carcinoma after Kidney transplantation: USRDS experience.
- Racial variation in medical outcomes among living Kidney donors.
- Renal function and healthcare costs in patients with polycystic Kidney disease.
- Cardiovascular risk assessment among potential Kidney transplant candidates: approaches and controversies.
- The impact of Kidney transplantation on heart failure risk varies with candidate body mass index.
- Liver transplantation cost in the model for end-stage liver Disease era: looking beyond the transplant admission.
- Increasing incidence of new-onset Diabetes after transplant among pediatric renal transplant patients.
- The role of positive flow cytometry crossmatch in late Renal allograft loss.
- Sensitivity of billing claims for cardiovascular disease events among Kidney transplant recipients.
- Early outcomes of thymoglobulin and basiliximab induction in Kidney transplantation: application of statistical approaches to reduce bias in observational comparisons.
- Bariatric surgery among Kidney transplant candidates and recipients: analysis of the United States renal data system and literature review.
- Incremental value of the pancreas allograft to the survival of simultaneous pancreas-Kidney transplant recipients.
- Incidence, predictors, and associated outcomes of prostatism after Kidney transplantation.
- Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after Kidney transplantation.
- Obesity and cardiac risk after Kidney transplantation: experience at one center and comprehensive literature review.
- Variations in the risk for cerebrovascular events after Kidney transplant compared with experience on the waiting list and after graft failure.
- Cardiac evaluation before Kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients.
- Assessment of racial disparities in chronic Kidney disease stage 3 and 4 care in the department of defense health system.
- Incidence and risk factors for diarrhea following Kidney transplantation and association with graft loss and mortality.
- Increased risk of graft failure in Kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease.
- Flow cytometry crossmatch before Kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
- Novel methods for tracking long-term maintenance immunosuppression regimens.
- The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage.
- Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset Diabetes.
- Diabetic complications associated with new-onset Diabetes mellitus in renal transplant recipients.
- Agreement of immunosuppression regimens described in Medicare pharmacy claims With the Organ Procurement and Transplantation Network survey.
- Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft Failure.
- Use of beta-blockers and aspirin after myocardial infarction by patient Renal function in the Department of Defense health care system.
- Incidence, predictors, and associated outcomes of atrial fibrillation after Kidney transplantation.
- The cost effectiveness of deceased organ donation.
- Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients.
- De novo congestive heart failure after Kidney transplantation: a common condition with poor prognostic implications.
- Maintenance immunosuppression use and the associated risk of avascular necrosis after Kidney transplantation in the United States.
- Incidence and predictors of myocardial infarction after Kidney transplantation.
- Impact of diabetes and hepatitis after Kidney transplantation on patients who are affected by hepatitis C virus.
- Outcomes associated with recipient and donor hepatitis C serology status after Kidney transplantation in the United States: analysis of the USRDS/UNOS database.
- Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality.
- Immune-complex deposits in "pauci-Immune" glomerulonephritis: a case report and brief review of recent literature.
- MELD Exceptions and Rates of Waiting List Outcomes.
- Renal function following living, standard criteria deceased and expanded criteria deceased donor Kidney transplantation: impact on graft failure and death.
- The economic implications of broader sharing of liver allografts.
- Transplant outcomes and economic costs associated With patient noncompliance to immunosuppression.
- The clinical importance of flow cytometry crossmatch in the context of CDC crossmatch results.
- Three-year post-transplant Medicare payments in Kidney transplant recipients: associations with pre-transplant comorbidities.
- Incidence, predictors and associated outcomes of rhabdomyolysis after Kidney transplantation.
- Incidence, predictors and outcomes of transplant renal artery stenosis after Kidney transplantation: analysis of USRDS.
- Recognition of downhill esophageal varices in hemodialysis patients requires a high index of clinical suspicion.
- Crossmatch testing in Kidney transplantation: patterns of practice and associations with rejection and graft survival.
- The cost and quality paradox.
- Predictive ability of pretransplant comorbidities to predict long-term graft loss and death.
- Association of lower costs of pulsatile machine perfusion in Renal transplantation from expanded criteria donors.
- Income-related disparities in Kidney transplant graft failures are eliminated by Medicare''s immunosuppression coverage.
- Delivery patterns of recommended chronic Kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review.
- Formation of downhill esophageal varices as a rare but serious complication of hemodialysis access: a case report and comprehensive literature review.
- A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in Kidney transplant recipients.
- Patient and graft survival implications of simultaneous pancreas Kidney transplantation from old donors.
- Associations of serologic markers of infection and inflammation with vascular Disease events and mortality in American dialysis patients.
- Is there a correlation between atherosclerosis and renal resistive indices in Kidney transplant recipients?
- Lack of interventional studies in renal transplant candidates With elevated cardiovascular risk.
- Health insurance considerations for adolescent transplant recipients as they transition to adulthood.
- Application of diagnostic classification algorithms to identify the most common causes of post-transplant complications.
- The life-years saved by a deceased organ donor.
- Diabetic muscle infarction in end-stage renal Disease.
- New insights into protein intake and progression of renal Disease.
- Statin use after Renal transplantation: a systematic quality review of trial-based evidence.
- The impact of transplantation with deceased donor hepatitis c-positive Kidneys on survival in wait-listed long-term dialysis patients.
- The promise and pitfalls of transplant centers.
- A developmentally regulated chromosomal origin of replication uses essential transcription elements.
- Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data.
Schools
Stanford University School Of Medicine
Procedures Preformed
- End-Stage Renal Disease Related Services
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Blue Preferred Select
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Kansas, Inc. PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- HealthLink PPO
- Homestate Health Plan
- Choice Care PPO
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (ASNF)
Education
-
Washington University -
Stanford University -
Stanford University School of Medicine
Drug Facts
| NPI NUMBER | 1033223961 | |
| NPPES Provider LastName | LENTINE | |
| NPPES Provider FirstName | KRISTA | |
| NPPES Provider ZIPCode | 631102540 | |
| NPPES Provider State | MO | |
| Specialty Description | Nephrology | |
| Total Claim Count | 281.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033223961 |
| Last Name Of The Provider | LENTINE |
| First Name Of The Provider | KRISTA |
| View All |
Similar Doctors
|
|
Dr. Humayun Quadir, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley W. Buck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Mellas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bhavani Adusumilli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judy L. Jang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arvind K. Garg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meher S. Mallick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Decha Enkvetchakul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anitha Vijayan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sagar Gupta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik D. Daniels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anahit S. Cheema, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh Mathew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Siedlecki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thin T. Maw, MD
This Doctor is OpenDoctor Recommended.
|